You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
百濟神州(06160.HK)下月於滬科創板招股
百濟神州(06160.HK)於上交所發佈科創板上市的招股意向書,股號爲(688235.SH),擬公開發行約1.15億股A股,佔公司於10月31日已發行股份總數及此次擬公開發行股份數量之和的8.62%,初步詢價日爲11月29日,網上申購日爲12月2日,網上繳款日及截止時間爲12月6日,每股發售價待定。聯席保薦機構爲中金及高盛高華證券。 公司指出,是次上市淨集資款項擬用作藥物臨牀試驗研發項目、研發中心建設項目、生產基地建設研發及產業化項目、營銷網絡建設項目,以及補充流動資金。 由於百濟神州上市申請早前已獲通過,預期將成爲同時在美國、香港及中國掛牌的生物醫藥股。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account